TPC
AKLI

Takeda Pharmaceutical Company’s Akili, Inc. Common Stock AKLI Stock Holding History

Takeda Pharmaceutical Company’s Portfolio AKLI Stock Details AKLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-738,819
Closed -$321K – 13
2024
Q2 		$321K Hold
738,819
– – 0.14% 12
2024
Q1 		$214K Hold
738,819
– – 0.07% 14
2023
Q4 		$360K Buy
+738,819
New +$360K 0.11% 12